Skip to main content
Erschienen in: World Journal of Pediatrics 5/2018

03.10.2018 | Review Article

Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition)

verfasst von: Xing-Wang Li, Xin Ni, Su-Yun Qian, Quan Wang, Rong-Meng Jiang, Wen-Bo Xu, Yu-Cai Zhang, Guang-Jun Yu, Qiang Chen, Yun-Xiao Shang, Cheng-Song Zhao, Hui Yu, Ting Zhang, Gang Liu, Hui-Ling Deng, Jie Gao, Xian-Gui Ran, Qiao-Zhi Yang, Bian-Li Xu, Xue-Yong Huang, Xing-Dong Wu, Yi-Xiao Bao, Yi-Ping Chen, Zhi-Hai Chen, Qing-Quan Liu, Guo-Ping Lu, Chun-Feng Liu, Rong-Bing Wang, Guo-Liang Zhang, Fang Gu, Hong-Mei Xu, Ying Li, Tao Yang

Erschienen in: World Journal of Pediatrics | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Hand, foot, and mouth disease (HFMD) is a common infectious disease in childhood caused by an enterovirus (EV), and which is principally seen in children under 5 years of age. To promote diagnostic awareness and effective treatments, to further standardize and strengthen the clinical management and to reduce the mortality of HFMD, the guidelines for diagnosis and treatment have been developed.

Methods

National Health Commission of China assembled an expert committee for a revision of the guidelines. The committee included 33 members who are specialized in diagnosis and treatment of HFMD.

Results

Early recognition of severe cases is utmost important in diagnosis and treatment of patients with HFMD. The key to diagnosis and treatment of severe cases lies in the timely and accurate recognition of stages 2 and 3 of HFMD, in order to stop progression to stage 4. Clinicians should particularly pay attention to those EV-A71 cases in children aged less than 3 years, and those with disease duration less than 3 days. The following indicators should alert the clinician of possible deterioration and impending critical disease: (1) persistent hyperthermia; (2) involvement of nervous system; (3) worsening respiratory rate and rhythm; (4) circulatory dysfunction; (5) elevated peripheral WBC count; (6) elevated blood glucose and (7) elevated blood lactic acid. For treatment, most mild cases can be treated as outpatients. Patients should be isolated to avoid cross-infection. Intense treatment modalities should be given for those severe cases.

Conclusion

The guidelines can provide systematic guidance on the diagnosis and management of HFMD.
Literatur
1.
Zurück zum Zitat Zhang SB, Liao H, Huang CH, Tan QY, Zhang WL, Huang Y, et al. Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen. Chin J Contemp Pediatr. 2008;10:38–41 (in Chinese). Zhang SB, Liao H, Huang CH, Tan QY, Zhang WL, Huang Y, et al. Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen. Chin J Contemp Pediatr. 2008;10:38–41 (in Chinese).
2.
Zurück zum Zitat Song Y, Zhang Y, Ji T, Gu X, Yang Q, Zhu S, et al. Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015. Sci Rep. 2017;7:5491 (in Chinese). CrossRefPubMedCentralPubMed Song Y, Zhang Y, Ji T, Gu X, Yang Q, Zhu S, et al. Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015. Sci Rep. 2017;7:5491 (in Chinese)CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Tan XJ, Huang XY, Zhu SL, Chen H, Yu QL, Wang HY, et al. The persistent circulation of enterovirus 71 in People’s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011;6:e25662.CrossRefPubMedCentralPubMed Tan XJ, Huang XY, Zhu SL, Chen H, Yu QL, Wang HY, et al. The persistent circulation of enterovirus 71 in People’s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One. 2011;6:e25662.CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Zhou HT. Epidemiological and clinical characteristics of hand, foot and mouth disease in Guangdong Province during 2009–2013. South Med Univ. 2014. Zhou HT. Epidemiological and clinical characteristics of hand, foot and mouth disease in Guangdong Province during 2009–2013. South Med Univ. 2014.
5.
Zurück zum Zitat Yang YP, Chen MM, Ju Y, Wang J, Huang J, Tan Y. Epidemiology and pathogen distribution of hand-foot-mouth disease in Guangxi, 2008–2014. Appl Prev Med. 2015;21:365–8. Yang YP, Chen MM, Ju Y, Wang J, Huang J, Tan Y. Epidemiology and pathogen distribution of hand-foot-mouth disease in Guangxi, 2008–2014. Appl Prev Med. 2015;21:365–8.
6.
Zurück zum Zitat Chen GP, Shi YL, Zhang J, Cao MH, Wu JB, Hu WF, et al. Analysis of the epidemiological characteristics of hand-foot-and-mouth disease in Anhui Province between 2008 and 2014. Mod Prev Med. 2016;43:588–90. Chen GP, Shi YL, Zhang J, Cao MH, Wu JB, Hu WF, et al. Analysis of the epidemiological characteristics of hand-foot-and-mouth disease in Anhui Province between 2008 and 2014. Mod Prev Med. 2016;43:588–90.
7.
Zurück zum Zitat Bo YC, Song C, Wang JF, Li XW. Using an autologistic regression model to identify spatial risk factors and spatial risk patterns of hand, foot and mouth disease (HFMD) in Mainland China. BMC Public Health. 2014;14:1–13.CrossRef Bo YC, Song C, Wang JF, Li XW. Using an autologistic regression model to identify spatial risk factors and spatial risk patterns of hand, foot and mouth disease (HFMD) in Mainland China. BMC Public Health. 2014;14:1–13.CrossRef
8.
Zurück zum Zitat Zhang C. The study of epidemiology and influencing factors of hand, foot and mouth disease in Guangxi Province from, 2008 to 2015. Guangxi Med Univ J. 2016:1–69 (in Chinese). Zhang C. The study of epidemiology and influencing factors of hand, foot and mouth disease in Guangxi Province from, 2008 to 2015. Guangxi Med Univ J. 2016:1–69 (in Chinese).
9.
Zurück zum Zitat Zhao J, Jiang F, Zhong L, Sun J, Ding J. Age patterns and transmission characteristics of hand, foot and mouth disease in China. BMC Infect Dis. 2016;16:691. CrossRefPubMedCentralPubMed Zhao J, Jiang F, Zhong L, Sun J, Ding J. Age patterns and transmission characteristics of hand, foot and mouth disease in China. BMC Infect Dis. 2016;16:691. CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Yu P, Bao L, Xu L, Li F, Lv Q, Deng W, et al. Neurotropism in vitro and mouse models of severe and mild infection with clinical strains of enterovirus 71. Viruses. 2017;9:351. CrossRefPubMedCentral Yu P, Bao L, Xu L, Li F, Lv Q, Deng W, et al. Neurotropism in vitro and mouse models of severe and mild infection with clinical strains of enterovirus 71. Viruses. 2017;9:351. CrossRefPubMedCentral
11.
Zurück zum Zitat Xing J, Liu D, Shen S, Su Z, Zhang L, Duan Y, et al. Pathologic studies of fatal encephalomyelitis in children caused by enterovirus 71. Am J Clin Pathol. 2016;146:95–106.CrossRefPubMed Xing J, Liu D, Shen S, Su Z, Zhang L, Duan Y, et al. Pathologic studies of fatal encephalomyelitis in children caused by enterovirus 71. Am J Clin Pathol. 2016;146:95–106.CrossRefPubMed
12.
Zurück zum Zitat Wu J, Cheng YB, Li ZF, Li YF, Li YP, Xu HM, et al. Evaluation of adrenocortical function in children with severe and critical enterovirus 71 infection. Chin J Pediatr. 2012;50:249–54 (in Chinese). Wu J, Cheng YB, Li ZF, Li YF, Li YP, Xu HM, et al. Evaluation of adrenocortical function in children with severe and critical enterovirus 71 infection. Chin J Pediatr. 2012;50:249–54 (in Chinese)
13.
Zurück zum Zitat Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85:69–77.CrossRefPubMed Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85:69–77.CrossRefPubMed
14.
Zurück zum Zitat Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778–90.CrossRefPubMed Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778–90.CrossRefPubMed
15.
Zurück zum Zitat Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol. 2000;17:13–22. CrossRefPubMed Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol. 2000;17:13–22. CrossRefPubMed
16.
Zurück zum Zitat Hu J, Shi XH, Tang Y, Ge XH, Yu Y, Yang J, et al. Analysis of course of 94 cases of severe hand, foot and mouth disease complicated with viral meningitis encephalitis. Acta Univ Med Nanjing (Nat Sci). 2009;29:1616–8 (in Chinese). Hu J, Shi XH, Tang Y, Ge XH, Yu Y, Yang J, et al. Analysis of course of 94 cases of severe hand, foot and mouth disease complicated with viral meningitis encephalitis. Acta Univ Med Nanjing (Nat Sci). 2009;29:1616–8 (in Chinese).
17.
Zurück zum Zitat Chen HI, Liao JF, Kuo L, Ho ST. Centrogenic pulmonary hemorrhagic edema induced by cerebral compression in rats. Mechanism of volume and pressure loading in the pulmonary circulation. Circ Res. 1980;47:366–73. CrossRefPubMed Chen HI, Liao JF, Kuo L, Ho ST. Centrogenic pulmonary hemorrhagic edema induced by cerebral compression in rats. Mechanism of volume and pressure loading in the pulmonary circulation. Circ Res. 1980;47:366–73. CrossRefPubMed
18.
Zurück zum Zitat Maron MB, Holcomb PH, Dawson CA, Rickaby DA, Clough AV, Linehan JH. Edema development and recovery in neurogenic pulmonary edema. J Appl Physiol. 1994;77:1155–63. CrossRefPubMed Maron MB, Holcomb PH, Dawson CA, Rickaby DA, Clough AV, Linehan JH. Edema development and recovery in neurogenic pulmonary edema. J Appl Physiol. 1994;77:1155–63. CrossRefPubMed
19.
20.
Zurück zum Zitat Wu JM, Wang JN, Tsai YC, Liu CC, Huang CC, Chen YJ, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002;109:E26.CrossRefPubMed Wu JM, Wang JN, Tsai YC, Liu CC, Huang CC, Chen YJ, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002;109:E26.CrossRefPubMed
21.
Zurück zum Zitat Fu YC, Chi CS, Chiu YT, Hsu SL, Hwang B, Jan SL, et al. Cardiac complications of enterovirus rhombencephalitis. Arch Dis Child. 2004;89:368–73. CrossRefPubMedCentralPubMed Fu YC, Chi CS, Chiu YT, Hsu SL, Hwang B, Jan SL, et al. Cardiac complications of enterovirus rhombencephalitis. Arch Dis Child. 2004;89:368–73. CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Clinical Experts Group of the Ministry of Health for Hand, Foot and Mouth Disease. Experts consensus on rescue and treatment of severe cases with enterovirus 71 (EV71) infection. Zhonghua Er Ke Za Zhi. 2011;49:675–8 (in Chinese). Clinical Experts Group of the Ministry of Health for Hand, Foot and Mouth Disease. Experts consensus on rescue and treatment of severe cases with enterovirus 71 (EV71) infection. Zhonghua Er Ke Za Zhi. 2011;49:675–8 (in Chinese)
23.
Zurück zum Zitat Wang XW, Zhong TY, Tian Y. Analysis of myocardial zymogram in children with severe hand, foot and mouth disease. Med J Nat Defending Forces Southwest China. 2009;19:1001–2 (in Chinese). Wang XW, Zhong TY, Tian Y. Analysis of myocardial zymogram in children with severe hand, foot and mouth disease. Med J Nat Defending Forces Southwest China. 2009;19:1001–2 (in Chinese)
25.
Zurück zum Zitat Gmitterová K, Heinemann U, Krasnianski A, Gawinecka J, Zerr I. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease. Eur J Neurol. 2016;23:1126–33. CrossRefPubMed Gmitterová K, Heinemann U, Krasnianski A, Gawinecka J, Zerr I. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease. Eur J Neurol. 2016;23:1126–33. CrossRefPubMed
26.
Zurück zum Zitat Wu YD, Shang SQ, Chen ZM, Yang ZH. Analysis of the epidemic characteristics of the etiological agents in children with hand, foot and mouth disease and its clinical significance. Zhonghua Er Ke Za Zhi. 2010;48:535–9 (in Chinese). PubMed Wu YD, Shang SQ, Chen ZM, Yang ZH. Analysis of the epidemic characteristics of the etiological agents in children with hand, foot and mouth disease and its clinical significance. Zhonghua Er Ke Za Zhi. 2010;48:535–9 (in Chinese)PubMed
27.
Zurück zum Zitat Jin L, Huang XM. HFMD rash and the identification. Med Recapitulate. 2012;18:1680–3. Jin L, Huang XM. HFMD rash and the identification. Med Recapitulate. 2012;18:1680–3. 
28.
Zurück zum Zitat Wang J, Campbell IL, Zhang H. Systemic interferon-a regulates interferon-stimulated genes in the central nervous system. Mol Psychiatry. 2008;13:293–301. CrossRefPubMed Wang J, Campbell IL, Zhang H. Systemic interferon-a regulates interferon-stimulated genes in the central nervous system. Mol Psychiatry. 2008;13:293–301. CrossRefPubMed
29.
Zurück zum Zitat Qiu J, Lu XL, Liu X, Zhang P, Zhao W, Liu P, et al. Derivation and validation of a mortality risk score for severe hand, foot and mouth disease in China. Sci Rep. 2017;7:3371. CrossRefPubMedCentralPubMed Qiu J, Lu XL, Liu X, Zhang P, Zhao W, Liu P, et al. Derivation and validation of a mortality risk score for severe hand, foot and mouth disease in China. Sci Rep. 2017;7:3371. CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat Lu GP. Diagnosis and treatment of neurogenic pulmonary edema in children with severe hand, foot and mouth disease. Chin Pediatr Emerg Med. 2011;18:8–10 (in Chinese). Lu GP. Diagnosis and treatment of neurogenic pulmonary edema in children with severe hand, foot and mouth disease. Chin Pediatr Emerg Med. 2011;18:8–10 (in Chinese)
31.
Zurück zum Zitat Mao YY, Yao JH, Cao LF, Wang QL, Chen LH, Si MQ. Analysis of the treatment response and prognosis of severe hand-foot-mouth disease. Chin J Infect Dis. 2009;27:35–8 (in Chinese). Mao YY, Yao JH, Cao LF, Wang QL, Chen LH, Si MQ. Analysis of the treatment response and prognosis of severe hand-foot-mouth disease. Chin J Infect Dis. 2009;27:35–8 (in Chinese)
32.
Zurück zum Zitat Huang T, Li QF, Shen XL, Fu XQ, Cun JP. Analysis of the risk factors for severe hand-foot-and-mouth disease (HFMD) in Yunnan Province. Mod Prev Med. 2017;44:1115–9. Huang T, Li QF, Shen XL, Fu XQ, Cun JP. Analysis of the risk factors for severe hand-foot-and-mouth disease (HFMD) in Yunnan Province. Mod Prev Med. 2017;44:1115–9.
33.
Zurück zum Zitat Sasaki O, Karaki T, Imanishi J. Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J Infect Dis. 1986;153:498–502. CrossRefPubMed Sasaki O, Karaki T, Imanishi J. Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J Infect Dis. 1986;153:498–502. CrossRefPubMed
34.
Zurück zum Zitat Huang Y. Curative effect observation on recombinant human interferon α2b Spray in hand-foot-and-mouth disease. China Pract Med. 2014;9:47–8 (in Chinese). Huang Y. Curative effect observation on recombinant human interferon α2b Spray in hand-foot-and-mouth disease. China Pract Med. 2014;9:47–8 (in Chinese)
35.
Zurück zum Zitat Lin H, Huang L, Zhou J, Lin K, Wang H, Xue X, et al. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Adv Virol. 2016;161:1–8. Lin H, Huang L, Zhou J, Lin K, Wang H, Xue X, et al. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Adv Virol. 2016;161:1–8.
36.
Zurück zum Zitat Cao L, Zhang L, Tian L, Deng J. Antivirus effects and clinical evaluation of recombinant human interferon α2b spray. Chin Med Biotechnol. 2011;6:334–6 (in Chinese). CrossRef Cao L, Zhang L, Tian L, Deng J. Antivirus effects and clinical evaluation of recombinant human interferon α2b spray. Chin Med Biotechnol. 2011;6:334–6 (in Chinese)CrossRef
37.
Zurück zum Zitat Wei CH. Clinical and Virological Efficacy of Recombine Human Interferon α-2b for Hand-foot-mouth Disease in Children. Eval Anal Drug-use Hosp China. 2013;13:1018–20 (in Chinese). Wei CH. Clinical and Virological Efficacy of Recombine Human Interferon α-2b for Hand-foot-mouth Disease in Children. Eval Anal Drug-use Hosp China. 2013;13:1018–20 (in Chinese)
38.
Zurück zum Zitat Zong WY. Observation of the effects of adjunctive therapy of recombinant human interferon α2b Spray on hand, foot and mouth disease. Hebei Med J. 2011;33:2808–9 (in Chinese). Zong WY. Observation of the effects of adjunctive therapy of recombinant human interferon α2b Spray on hand, foot and mouth disease. Hebei Med J. 2011;33:2808–9 (in Chinese)
39.
Zurück zum Zitat Huang X, Zhang X, Wang F, Wei H, Ma H, Sui M, et al. Clinical efficacy of therapy with recombinant human interferon α1b in hand, foot, and mouth disease with enterovirus 71 infection. PLoS One. 2016;11:e0148907.CrossRefPubMedCentralPubMed Huang X, Zhang X, Wang F, Wei H, Ma H, Sui M, et al. Clinical efficacy of therapy with recombinant human interferon α1b in hand, foot, and mouth disease with enterovirus 71 infection. PLoS One. 2016;11:e0148907.CrossRefPubMedCentralPubMed
40.
Zurück zum Zitat Tan J, Wang WM, Lei KJ. Gamma globulin intravenous drip combined with interferon aerosol inhalation on severe hand, foot and mouth disease in children. J Pediatr Pharm. 2017;23:21–3. Tan J, Wang WM, Lei KJ. Gamma globulin intravenous drip combined with interferon aerosol inhalation on severe hand, foot and mouth disease in children. J Pediatr Pharm. 2017;23:21–3.
41.
Zurück zum Zitat Zhang XD, Tian YK, Xiong F, Mou DL, Wang W. Clinical observation of recombinant human interferon α-2b injection by aerosol inhalation in treatment of hand-foot-mouth disease of children. Drugs Clin. 2014;29:404–7 (in Chinese). Zhang XD, Tian YK, Xiong F, Mou DL, Wang W. Clinical observation of recombinant human interferon α-2b injection by aerosol inhalation in treatment of hand-foot-mouth disease of children. Drugs Clin. 2014;29:404–7 (in Chinese)
42.
Zurück zum Zitat Zeng JS, Qian SY. Characteristics and diagnosis and treatment for severe hand foot and mouth disease. Chin J Crit Care Med. 2008;28:752–3 (in Chinese). Zeng JS, Qian SY. Characteristics and diagnosis and treatment for severe hand foot and mouth disease. Chin J Crit Care Med. 2008;28:752–3 (in Chinese)
43.
Zurück zum Zitat Li YL, Wang WH, Yang HR. Efficacy observation on the treatment of hand foot mouth disease by Multi-channel application of interferon α-2b. Tianjin Med J. 2013;41:78–9 (in Chinese). Li YL, Wang WH, Yang HR. Efficacy observation on the treatment of hand foot mouth disease by Multi-channel application of interferon α-2b. Tianjin Med J. 2013;41:78–9 (in Chinese)
44.
Zurück zum Zitat Xu Y, Li Y, Chen Y, Xin S, Xie L, Liang Y, et al. A multicenter and contrasted clinical study on efficacy and safety of recombinant human interferon α2b spray in the treatment of hand-foot-and-mouth disease in kids. Chin J Infect Dis. 2018;36:101–7 (in Chinese). Xu Y, Li Y, Chen Y, Xin S, Xie L, Liang Y, et al. A multicenter and contrasted clinical study on efficacy and safety of recombinant human interferon α2b spray in the treatment of hand-foot-and-mouth disease in kids. Chin J Infect Dis. 2018;36:101–7 (in Chinese).
45.
Zurück zum Zitat Chi CY, Khanh TH, le Thoa PK, Tseng FC, Wang SM, le Thinh Q, et al. Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. Crit Care Med. 2013;41:1754–60.CrossRefPubMed Chi CY, Khanh TH, le Thoa PK, Tseng FC, Wang SM, le Thinh Q, et al. Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial. Crit Care Med. 2013;41:1754–60.CrossRefPubMed
46.
Zurück zum Zitat Wang SM, Lei HY, Huang MC, Su LY, Lin HC, Yu CK, Wang JL, Liu CC. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37:47–52. CrossRefPubMed Wang SM, Lei HY, Huang MC, Su LY, Lin HC, Yu CK, Wang JL, Liu CC. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37:47–52. CrossRefPubMed
47.
Zurück zum Zitat Ye N, Gong X, Pang LL, Gao WJ, Zhang YT, Li XL, et al. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225. CrossRefPubMedCentralPubMed Ye N, Gong X, Pang LL, Gao WJ, Zhang YT, Li XL, et al. Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis. 2015;15:225. CrossRefPubMedCentralPubMed
48.
Zurück zum Zitat Zeng M, Zheng X, Wei R, Zhang N, Zhu K, Xu B, et al. The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis. 2013;7:e2599.CrossRefPubMedCentralPubMed Zeng M, Zheng X, Wei R, Zhang N, Zhu K, Xu B, et al. The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis. 2013;7:e2599.CrossRefPubMedCentralPubMed
49.
Zurück zum Zitat Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818–28. CrossRefPubMed Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370:818–28. CrossRefPubMed
50.
Zurück zum Zitat Hu YM, Wang X, Wang JZ, Wang L, Zhang YJ, Chang L, et al. Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6–59 months. Clin Vaccine Immunol. 2013;12:1805–11. CrossRef Hu YM, Wang X, Wang JZ, Wang L, Zhang YJ, Chang L, et al. Immunogenicity, safety, and lot consistency of a novel inactivated enterovirus 71 vaccine in Chinese children aged 6–59 months. Clin Vaccine Immunol. 2013;12:1805–11. CrossRef
51.
Zurück zum Zitat Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multi centre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–32. CrossRefPubMed Zhu FC, Meng FY, Li JX, Li XL, Mao QY, Tao H, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multi centre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381:2024–32. CrossRefPubMed
52.
Zurück zum Zitat Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829–37.CrossRefPubMed Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014;370:829–37.CrossRefPubMed
Metadaten
Titel
Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition)
verfasst von
Xing-Wang Li
Xin Ni
Su-Yun Qian
Quan Wang
Rong-Meng Jiang
Wen-Bo Xu
Yu-Cai Zhang
Guang-Jun Yu
Qiang Chen
Yun-Xiao Shang
Cheng-Song Zhao
Hui Yu
Ting Zhang
Gang Liu
Hui-Ling Deng
Jie Gao
Xian-Gui Ran
Qiao-Zhi Yang
Bian-Li Xu
Xue-Yong Huang
Xing-Dong Wu
Yi-Xiao Bao
Yi-Ping Chen
Zhi-Hai Chen
Qing-Quan Liu
Guo-Ping Lu
Chun-Feng Liu
Rong-Bing Wang
Guo-Liang Zhang
Fang Gu
Hong-Mei Xu
Ying Li
Tao Yang
Publikationsdatum
03.10.2018
Verlag
Childrens Hospital, Zhejiang University School of Medicine
Erschienen in
World Journal of Pediatrics / Ausgabe 5/2018
Print ISSN: 1708-8569
Elektronische ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-018-0189-8

Weitere Artikel der Ausgabe 5/2018

World Journal of Pediatrics 5/2018 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.